Document Detail


Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up.
MedLine Citation:
PMID:  1899079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty-two women with symptomatic uterine myomas, candidates for myomectomy or hysterectomy, were randomized to 6 months' treatment with buserelin 1200 micrograms/day intranasally (n = 22) or immediate surgery (n = 20). After buserelin treatment or operation the patients were followed for at least 12 months. Buserelin was well tolerated, the uterine volume fell from 465 +/- 168 to 273 +/- 88 cm3, and hemoglobin values normalized in all anemic patients. Rapid myoma regrowth was observed in all patients in the buserelin group after treatment withdrawal. Pregnancy occurred during follow-up in one of five buserelin-treated myomectomy candidates. Menorrhagia recurred in eight of 15 buserelin-treated hysterectomy candidates, and a hysterectomy was required but no transfusion was needed. Two women entered natural menopause and were considered cured. In the surgery group all operations were uneventful: three women conceived after myomectomy, whereas four of the patients that underwent hysterectomy required transfusions. Thus buserelin treatment appears to be indicated for infertile patients when surgery is contra-indicated or could cause adhesions, and for hysterectomy candidates in perimenopausal age and/or with secondary anemia.
Authors:
L Fedele; S Bianchi; A Baglioni; L Arcaini; M Marchini; L Bocciolone
Related Documents :
9856319 - Uterine balloon therapy to treat menorrhagia.
20486879 - A novel regimen of combination transdermal estrogen and intermittent vaginally administ...
17157099 - Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study r...
9132309 - Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacem...
20066419 - Uterine artery embolization in patients with a large fibroid burden: long-term clinical...
9660419 - Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization...
9626839 - Reversible restrictive left ventricular diastolic filling with optimized oral therapy p...
11677989 - Prospects in medical management of echinococcus granulosus.
16820609 - Perioperative increases in serum creatinine are predictive of increased 90-day mortalit...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European journal of obstetrics, gynecology, and reproductive biology     Volume:  38     ISSN:  0301-2115     ISO Abbreviation:  Eur. J. Obstet. Gynecol. Reprod. Biol.     Publication Date:  1991 Jan 
Date Detail:
Created Date:  1991-02-27     Completed Date:  1991-02-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375672     Medline TA:  Eur J Obstet Gynecol Reprod Biol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  53-7     Citation Subset:  IM    
Affiliation:
First Department of Obstetrics and Gynecology, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Adult
Analysis of Variance
Buserelin / administration & dosage*,  pharmacology
Female
Follow-Up Studies
Gonadotropin-Releasing Hormone / physiology
Humans
Hysterectomy
Leiomyoma / drug therapy*,  surgery
Middle Aged
Uterine Neoplasms / drug therapy*,  surgery
Chemical
Reg. No./Substance:
33515-09-2/Gonadotropin-Releasing Hormone; 57982-77-1/Buserelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regulation of autologous T-lymphocyte clones on in vitro growth of BFU-e: enhancing effects of both ...
Next Document:  Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.